In pharmaceutical research, high-content screening is an integral part of lead candidate development. Measuring drug response in vitro by examining over 40 parameters, including biomarkers, signaling molecules, cell morphological changes, proliferation indices and toxicity in a single sample, could significantly enhance discovery of new therapeutics. As a proof of concept, we present here a workflow for multidimensional Imaging Mass Cytometry™ (IMC™) and data processing with open source computational tools. CellProfiler was used to identify single cells through establishing cellular boundaries, followed by histoCAT™ (histology topography cytometry analysis toolbox) for extracting single-cell quantitative information visualized as t-SNE plots and heatmaps. Human breast cancer-derived cell lines SKBR3, HCC1143 and MCF-7 were screened for expression of cellular markers to generate digital images with a resolution comparable to conventional fluorescence microscopy. Predicted pharmacodynamic effects were measured in MCF-7 cells dosed with three target-specific compounds: growth stimulatory EGF, microtubule depolymerization agent nocodazole and genotoxic chemotherapeutic drug etoposide. We show strong pairwise correlation between nuclear markers pHistone3 S28 , Ki-67 and p4E-BP1 T37/T46 in classified mitotic cells and anticorrelation with cell surface markers. Our study demonstrates that IMC data expand the number of measured parameters in single cells and brings higher-dimension analysis to the field of cellbased screening in early lead compound discovery.
Introduction
Discovery of new treatments in oncology research relies extensively on the use of humanderived cell culture models [1] . High-content cell-based screens are widely applied in pharmaceutical drug development to prioritize lead molecules for animal testing [2] . These assays rely on the use of primary and cancer cell lines and mostly monitor cytotoxicity and proliferation. With the advent of sophisticated genomics and proteomics technologies for soluble proteins and mass cytometry for single cells, it is becoming possible to increase the multidimensionality of in vitro screens. Databases of genotypic and phenotypic profiles [3, 4, 5] across cancer drug panels have provided a comparative analysis between in vitro studies and clinical therapeutic responses in vivo [6] . One of these datasets developed and shared by the National Cancer Institute 60 (NCI-60) in the late 1980s was the first in vitro discovery screening tool for pharmacologic compounds inducing growth inhibition across 60 cancer cell lines [7] .
Over the years several concerns were raised regarding the use of in vitro established human tumor-derived cell lines for drug testing. Concerns included genetic instability and dedifferentiation. However, the study of genetic mutations arising in immortalized cells remained a field of interest in drug discovery, providing knowledge on the dysregulation of cellular signaling pathways and the effects small-molecule inhibitors have on human tumor cell lines [8] .
High-content imaging of cancer cell lines in response to drug treatment is a standard assay applied in preclinical studies for identification of different mechanisms of drug action [9, 10, 11, 12] . The main criteria in every morphophenotypic screen for early drug discovery is the selection of biomarkers and detection modalities (antibodies, chemical and enzymatic probes, reporter detection tags). In the field of fluorescent cellular imaging microscopy, biomarker analysis in single cells is limited to 4-6 due to the overlapping spectra of fluorescent dyes [13] . Repetitive rounds of staining using the same biological sample are required to achieve multiplexing [14] .
New imaging technologies are needed to significantly increase multiplicity in a single sample preparation experiment and perform replicate analyses [15] . High-content imaging assays applied to screening drug perturbations in heterogeneous cancer cell models could uncover additional modes of drug action and biomarkers for clinical trials [16] .
Imaging Mass Cytometry is an emerging and transformative technique in the field of digital histopathology applied to complex tissue sections [17, 18, 19] . The Hyperion™ Imaging System (Fluidigm ® ) can measure up to 40 parameters simultaneously in formalin-fixed, paraffinembedded (FFPE) and frozen human tissue sections with subcellular resolution [20] . Sample preparation is very similar to standard immunohistochemical protocols [17] , where the tissue section on a slide is first deparaffinized and treated with an antigen retrieval buffer for antigen epitope exposure in the case of FFPE, then stained once with a mixture of isotopically pure metal-labeled antibodies specific to structural and cell type biomarkers. After drying and inserting the slide into the ablation chamber, regions of interest (ROIs) are chosen and recorded by a camera integrated with the Hyperion Tissue Imager. These ROIs are then ablated in 1 μ m steps as the slide moves under the laser. Each laser pulse vaporizes a 1 μ m 2 area of the tissue and generates a plume of particles. The resulting particles are carried by a stream of helium/argon mixture into a CyTOF ® instrument, an inductively coupled plasma time-of-flight mass cytometer, described elsewhere [18] . Data are stored as raw binary files of ion counts for each mass channel (parameter) per pixel. These files can be converted into a stack of single-parameter matrices (grayscale images), which are used to create merged multiparametric pseudocolor images and perform quantitative pixel-or segmentation-based analysis. Bodenmiller et al. are developing multivariate computational tools to visualize and analyze multiplexed images of human tissue sections generated by IMC [21] . However, there is no single software package or analysis workflow that could currently be applied to answer specific biological questions.
In this proof-of-principle study, we set out to develop a comprehensive workflow for IMC data analysis based on recent advances in imaging algorithmic methods to visualize and measure multiple biomarkers in model cell lines cultured in chamber slides (Fig. 1) . Several human breast cancer-derived cell lines, SKBR3, HCC1143 and MCF-7, were screened for expression of surface and intracellular markers. Predicted pharmacodynamic effects were studied in MCF-7 cells dosed with three target-specific compounds: growth stimulatory epidermal growth factor (EGF), microtubule depolymerization agent nocodazole and genotoxic chemotherapeutic drug etoposide [22, 23] . Our method analysis workflow demonstrates the high multiplexing capability of IMC for in vitro research and offers quantitation of multiple biomarkers at subcellular resolution. Future improvements of the technology toward a higher acquisition speed of multiple samples will expand IMC applications as an imaging platform for in vitro cell-based drug screening. humidity for 48 hours prior to drug compound addition. Each breast cancer cell line was seeded using individual chamber slides to avoid any cell cross-contamination, and each IMC experiment was carried out independently. In chronological order, seeding of HCC1143 was the first sample preparation, then we run the second experiment using SKBR3, and last we used MCF-7 for the drug-treated cells in vitro study.
Material and Methods

In vitro drug treatment
All chemical compounds were dissolved and aliquoted at the supplier's recommended concentrations for long-term storage in 100% DMSO (Sigma-Aldrich Cat. No. 276855). Final concentrations for each compound were selected from previously published data [32, 53, 54] by premixing the required initial drug stock volume with full growth media, then transferring 0.5 mL volume to corresponding cell chambers (see Supplementary Table S1 ): 10 µM of etoposide (Cell Signaling Technology® Cat. No. 2200S); 0.5 µM of nocodazole (Sigma-Aldrich Cat. No. M1404); 10 ng/mL of human EGF (Sigma-Aldrich Cat. No. E9644); 2% DMSO in growth media. One chamber was left with fresh growth media as non-treated control. Cells were exposed to compounds for 48 hours at 37 °C, 5% CO2 and 100% humidity. Preparation of additional eight chamber sample slides to replicate our experiment for IMC analysis was not required due to the known in vitro predicted effect of the drugs we tested on this cell line.
Immunocytochemistry and antibody validation
Immunostaining of live cells was performed in chamber slides. Following drug treatment, fresh media in all chambers was supplemented with Cell-ID™ Intercalator-103Rh (Fluidigm Cat. No.
201103A) at 1:500 for 15 minutes at 37 ºC, 5% CO2 for dead cell identification. The chamber slides were washed with DPBS (Thermo Fisher Scientific Cat. No. 14190-144) at room temperature (RT) for 5 minutes. Surface metal-labeled antibody cocktail (see Supplementary   Table S2 ) was made in 0.5% BSA/DPBS from antibody stocks at a dilution of 1:100 for each.
Cell monolayers were stained with 250 µL antibody mix for 120 minutes, RT. Supplementary Table S3) 
Image analysis software tools
For each recorded ROI, stacks of 16-bit and 32-bit single-channel TIFF files were exported from MCD binary files using MCD™ Viewer 1.0 (Fluidigm). Cell-based morphological segmentation was carried out with two image processing pipelines for 16-bit or 32-bit TIFF files and Analyst for downstream computational analysis [37] . Spatial distribution maps, dimensionality reduction and unsupervised clustering for 16-bit single images were performed using the histoCAT 1.73 open source toolbox [21] . Supervised analysis by support vector machine learning classification on 32-bit datasets was processed with CellProfiler Analyst 2.2.1 [38] . Hierarchical clustering and correlation heat maps of classified cell populations were prepared using the webbased tool Morpheus (GenePattern, Broad Institute) [39] . Clustering and visualization of different types of markers in classified populations of cells across all controls and drug treatments were performed with the free software environment R 3.5.3, the packages pheatmap 1.0.12, igraph 1.2.4 and edgebundleR 0.1.4 [58] .
Statistical analysis
Data from non-treated control, DMSO-only and drug-treated cells were analyzed using a nonparametric Mann-Whitney test with a two-tailed P value for every channel independently.
Statistical significance was defined as P <0.05. All statistical analysis was performed with GraphPad™ Prism ® 7.04 software [57] .
Results
Multiparametric characterization of breast cancer cell lines by IMC
IMC analysis revealed heterogeneity in the expression of surface, intracellular and nuclear markers in human breast cancer cell lines cultured in chamber slides. As an example, we selected the SKBR3 cell line, which is characterized by an invasive phenotype and increased proliferation in vitro and is used as a model to delineate mechanisms of resistance to ErbB2-targeted clinical therapies [24, 25] . As seen in 
In vitro drug effect profiling by IMC
To evaluate how IMC may be translated into future applications in the field of cell-based drug screening, we initiated a limited drug treatment study using one model breast cancer cell line.
The phenotypic and functional responses of wild-type p53-expressing MCF-7 cells to etoposide, nocodazole or EGF compounds were investigated. In preclinical in vitro drug screening, this model is considered to be reproducible, fast and inexpensive despite the lack of clinical correlation to drug response in vivo due to breast tumor heterogeneity [28] . To identify how these chemical compounds induce cytostatic and cytotoxic effects on this noninvasive luminal breast cancer cell line, we generated multiplexed pseudocolor images of affected cellular compartments ( Fig. 4) . For example, nuclear size and proliferative activity of each cell were analyzed using the nuclear intercalator-Ir stain (Cell-ID Intercalator-Ir), cell cycle-S phase marker (Cell-ID IdU), proliferation marker Ki-67, cell cycle regulatory proteins cyclin B1 and D3 and estrogen receptor alpha (ERα). Antibody against pH2A.X S139 was used as a nuclear marker for DNA double-strand breaks and pHistone3 S28 for mitotic cells. Cytoskeletal markers pan-keratin and cytokeratin 19
were used to follow changes in morphology and cell size. Drug response of MCF-7 morphology, adhesion and cell-to-cell interaction were visualized with surface membrane proteins, such as the membrane-bound mucin marker MUC-1 overexpressed in breast carcinoma [29] , cell adhesion molecule EpCAM, integrin CD29, tetraspanin CD81, the low-expressed epidermal growth factor receptor EGFR, regulators of integrin-mediated cell adhesion CD98 and CD47 [30] , and Ecadherin as epithelial interaction protein ( Supplementary Table S2 ).
Long-term exposure of MCF-7 cells to EGF induced significant morphological changes and an increase in cell size. Lineage shift from a classic epithelial cobblestone monolayer to a more invasive mesenchymal type was observed. The presence of large spindle-shaped cells that seemed to lose contact with other cells and migrate into empty spaces may be related to an increase in cell motility (Fig. 4A) . Activation of the EGFR signal transduction pathway by EGF is known to play a role in cellular motility and size increase in the tumor aggressiveness [31] .
Screening of MCF-7 cells treated with etoposide, nocodazole or EGF shows multivariate phenotypic response profiles compared to non-treated and DMSO-treated controls ( Supplementary Fig. S1 ).
Treatment of MCF-7 cells with the antineoplastic agent nocodazole resulted in an increase in the population of pHistone3 S28 -positive cells with a mitotic index three-fold higher compared to DMSO-treated or non-treated control ( Supplementary Table S4 ). Another cytostatic phenotype was observed after prolonged drug exposure: subpopulations of cyclin D3-positive and tetraploid cells exiting mitosis without cytokinesis as a result of microtubule disruption by nocodazole ( Fig. 4B) . Presence of cyclin D3-positive and tetraploid cells in the G1/S interphase confirms nocodazole effect on MCF-7 cell cycle [32] .
Incubation of MCF-7 with the anti-cancer agent etoposide shows inhibition of cell proliferation, elevated numbers of cells positive for nuclear pH2A.X S139 protein and compaction of the monolayer compared to EGF-or nocodazole-treated samples (Fig. 4C) . Exposure of tumorderived cell lines to this inhibitor induces the formation of a stable covalent topoisomerase IIcleaved DNA complex, which causes multiple breaks in double-stranded DNA. Etoposide treatment of MCF-7 activates phosphorylation of H2A.X, which is required for checkpoint-mediated cell cycle arrest, promotes DNA repair and maintains genomic stability.
Thus, pH2A.X S139 is a sensitive biomarker for measuring levels of drug-induced double-stranded DNA breaks in cancer cells [33] .
High-dimensional phenotype analysis of in vitro drug response
Multivariate phenotypic responses of MCF-7 cells following chemical perturbations were quantified with a set of available software tools. Unfortunately, there is no single software package for this type of analysis. Therefore, we employed a workflow that includes a wide variety of tools designed for cellular imaging. Hopefully, this work will underscore the need for software specifically developed for analysis of multiparametric data acquired by IMC.
First, we used CellProfiler 2.2.0 (CP) to identify single cells through establishing nuclear and cellular boundaries [34] . Accuracy and robustness of cell segmentation was assessed by using
Cell-ID Intercalator-Ir to identify cell nuclei and pan-keratin for cytoplasm ( Fig. 5A,   Supplementary Fig. S2A and S3) . The segmentation masks were generated for each ROI, then exported for further downstream analysis of changes in MCF-7 cellular phenotypes in response to drug treatment.
Second, to visualize and analyze data we used the open source platform histoCAT, which enables highly multiplexed, quantitative and detailed analysis of cell phenotypes, microenvironment interactions and tissue architecture [21] . The workflow of histoCAT consists of overlaying the segmentation masks previously generated by CP to extract single-cell level information.
To evaluate the diversity of phenotypic profiles collected from drug-treated MCF-7 cells, we then selected and generated Z-score normalized mean intensities of pHistone3 S28 and pH2AX S139 as drug-sensitive protein markers. Spatial heat maps of both channels were displayed for various drug-treated MCF-7 ROIs using a 99 th percentile cut-off (Figs 5B and 5C, Supplementary Fig.  S2B ). This quantitative and visual approach allows us to compare at the same scale the spatial distribution of these parameters between ROIs. For example, pH2A.X S139 nuclear expression level in etoposide-treated MCF-7 cells is higher than in nocodazole or EGF-treated cells on average. Mitotic cell marker pHistone3 S28 expression level in nocodazole-treated MCF-7 is twofold higher than those identified for other drugs. Related single-cell Z-score mean intensity values for nuclear markers (pHistone3 S28 , pH2A.X S139 , Ki-67, p4EBP1 T37/T46 , p53, cyclin D3), surface markers (CD98, CD81, CD29, CD49e, CD47) and cell size parameters (area, perimeter, major and minor axis lengths) were exported from each drug treatment dataset to assess statistically significant changes of protein expression levels and cellular morphology ( Fig. 5D and Supplementary Fig. S4 ). We can see differences between both controls and drug-treated samples in the expression of nuclear markers, with a co-increase of pH2A.X S139 and Ki-67 levels, Finally, the heterogeneity of MCF-7 cell phenotypes was analyzed using the t-distributed stochastic neighbor embedding (t-SNE) algorithm, a data dimensionality reduction method based on the similarity of selected markers or cell types [36] . We processed replicates of ROI for each compound using Z-score-normalized protein markers and cell size parameters to generate twodimensional t-SNE plots. This visualization tool shows signal distribution of phosphoproteins, size parameters and nuclear and cell surface membrane markers over the different ROIs ( Fig. 6A and Supplementary Fig. S5 ). For example, the population of mitotic cells was grouped in a single region on the map with high expression levels of p4EBP1 T37/T46 , pHistone3 S28 and Ki-67.
The high level of pH2A.X S139 was detected in the region of etoposide-treated cells and correlates with the strong Ir-intercalator signal due to compaction of cellular DNA in response to the drug.
Area plot reveals the presence of larger-size cells in EGF and nocodazole treatments, in line with
EGF-induced lineage shift and cytokinesis inhibition by nocodazole ( Fig. 6B) .
Classification of drug-treated MCF-7 phenotypic changes by support vector machine learning
Here we applied the support vector machine learning classification ruler termed Fast Gentle
Boosting for accurate IMC dataset multiparametric analysis of nuclear states of compoundtreated MCF-7 cells [37] . This classifier was integrated into CellProfiler Analyst (CPA) and
trained [38] to identify five different nuclear classes of MCF-7 cells: pHistone3 S28 -positive mitotic cells, pH2A.X S139 for cells undergoing DNA repair, p53 as tumor suppressor activation, cyclin D3 for G1/S transition in interphase and Ki-67 for proliferating cells. A composite image of all nuclear markers is shown in Fig. 7A . These single-cellular objects were then scored and classified for a supervised analysis of every protein marker and cell size parameter per specified nuclear subpopulation. Accuracy of image classification on each dataset of MCF-7 drug compound was evaluated by cross-validation between the true labeled cells as classification training set and the image full scoring as predicted label set for each nuclear class. Classification reports were displayed as confusion matrices where each value corresponds to average crossvalidation metrics between the trained (true label) and scored (predicted label) single-cell objects for each nuclear class on a performance scale from 0 to 1 ( Fig. 7B and Supplementary Fig. S6 ).
As shown, classification of each nuclear class per drug compound dataset shows relatively good performance between 0.5 and 1.
Raw mean intensity values of protein expression for each of the five nuclear markers were exported per classified MCF-7 population and compared to evaluate statistical significance ( Fig.   7C and Supplementary Fig. S7 ). Bar charts show various levels of protein markers among the five predicted classes of nuclear states, with higher protein detection in the corresponding class, except for the Ki-67 proliferative marker, which shows stronger detection in pHistone3 S28 mitotic cells.
Multiparametric MCF-7 drug compound data pre-labeled by nuclear classification were reprocessed using hierarchical clustering similarity heat maps. First, we computed pairwise similarities for each class of cells per drug exposure with Pearson correlation coefficient between each measured parameter. This method is applicable to non-normalized data and can be used when data measurements vary between samples. Similarity Pearson correlation heat maps were computed using the browser-based tool Morpheus [39] . The core interface in Morpheus is a graphical color heat map representing protein marker and size parameter measurements applied to each single-cell object. Determination of the Pearson correlation coefficient between each measured parameter generates a reorganized heat map of multiparametric similarity relationships for each classified MCF-7 drug dataset [40] . Using these hierarchical similarity clustering heat maps, we compared the grouping pattern of mitotic pHistone3 S28 -positive cells across the multiple ROIs of compound-treated MCF-7 ( Fig. 8 and Supplementary Fig. S8 ). Naturally The clustering of different types of markers in the class of pHistone3 S28 mitotic cells was measured by comparing the similarity level of each target-specific cluster across all controls and drug treatments. First, we reprocessed cell surface membrane CD markers for each treatment as a new hierarchical similarity heatmap by using Pearson correlation as distance metric and complete linkage method (Fig. 9A) . As expected, each individual cluster is aligned and identified around the matrix diagonal component. Both non-treated and DMSO controls group of protein markers show close similarities to each other, and low or negative correlation with drug-treated markers. We used a hierarchical visualization edge bundle circle plot diagram to highlight the positive intra and inter-similarities across surface membrane protein parameters (Fig. 9B) .
Visualization of the high pairwise correlations within each cluster is shown as edge connecting nodes, and bundled lines correspond to close inter-relationships between both control conditions.
Drug-treated clusters of proteins show poor or no interdependency. A similar visual workflow
was applied to the multivariate analysis by pairwise Pearson correlation of specific nuclear markers and cytoplasmic markers types (Supplementary Fig. S9 ).
Discussion
The goal of this study was to demonstrate a multidimensional IMC workflow and quantitative
data processing using open source computational tools for in vitro drug response research. The multiplexed measurements acquired from a single image may provide a more informative and reliable screening of drug leads for further clinical development [41] . In this work, phenotypic features of tumor-derived cell lines such as SKBR3, HCC1143 and MCF-7, which recapitulate different subtypes found in breast tumors, were characterized. The wild-type p53-expressing MCF-7 epithelial cell line, a model of luminal breast adenocarcinoma, was selected for in vitro drug treatment and exposed for 48 hours to three classes of bioactive compounds: EGF, nocodazole and etoposide. The cells were stained with a mixture of metal-tagged antibodies against cell membrane, cytoplasmic and nuclei markers and subjected to IMC. The panel of metal tag antibodies used in our study was designed to minimize any potential spill over crossinterference between neighbor isotopic mass channels [42, 43] . When analyzing our IMC data, we did not encounter strong and significant channel contamination from one metal labeled antibody to another. The collected data allowed us to develop a workflow for cellular imaging analysis, which relies on established computational methods [44] . Multiplexed images of cell compartments give a detailed and broad visualization of biomarker localization and cell size parameter changes. Cell-based morphological segmentation of generated digital images is a prerequisite to identify and export multiple features of interest at single-cell resolution.
Exploratory downstream analysis was performed with the histoCAT platform to generate, normalize, measure and compare multiple images according to their multidimensional content in the form of spatial distribution heat maps, dimensionality reduction and unsupervised clustering.
In this report, we also describe cell classification by machine learning to pre-label cells before measuring their multivariate similarities. Prior knowledge of different cellular states is important for the calculation of distance and similarity metrics between each marker in the evaluation of the heterogeneity of cells and the effects of different compounds on cancer cells [45] . In the example of pHistone3 S28 -positive mitotic cells, we generated a multivariate high-dimensional
heat map that allows a comparative study of mechanisms of action of multiple drugs. Additional nuclear classes such as pH2A.X S139 , p53, cyclin D3 and Ki-67 were analyzed using similar multiparametric clustering approaches (data not shown). The strategy could enable new ways to perform deep proteomic drug screening on different models for translational medicine and preclinical trials [46, 47] .
Other in vitro assays using stem cells, or co-cultures of different cell types, could be studied by IMC as an additional approach to designing high-content analysis to investigate cell-to-cell interactions and signaling. A recent targeted therapy against cancer oncogenes described a cytotoxic small-molecule compound that activated the steroid receptor signaling pathways and led to cell stress and death [48] . IMC may assist researchers to better understand perturbations in this and other pathways through high-dimensional analysis. Three-dimensional tumor spheroids grown in vitro are more representative of the complexity of cancer tissue than two-dimensional cell cultures and can be analyzed by IMC through the preparation of sections of FFPE pelleted spheroids [49] . We summarized in Table 1 several advantages and challenges during preparation on slide, staining procedure, acquisition by IMC and software data analysis for three different models of sample. IMC was useful in the biodistribution study of the platinum-containing anticancer drug cisplatin in pancreatic adenocarcinoma xenograft model and could be applied to the emerging metal-containing chemotherapies and photodynamic therapies, which are considered as alternative approaches to classic compounds [50, 51] . Therefore, the goal for IMC in preclinical screening of metallodrugs will be to efficiently and effectively identify cellular responses of in vitro tumor-derived cell lines for lead optimization in target-based drug discovery [52] . A comparison of IMC performance metrics to other high content imaging system technologies in the field of single cell analysis is shown in Table 2 .
In conclusion, we demonstrate a comprehensive image analysis workflow for cell-based IMC 
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Sample type Tissue sections (Frozen and FFPE)
Cell smear on microscopic slide (Liquid biopsy)
Adherent cell lines grown in chamber slides
Sample quality and integrity criteria
• Thin thickness of the cut tissue slice (5µm).
• Effectiveness of tissue fixation for FFPE (temperature, fixing chemicals, pH, time).
• Storage conditions for tissue preservation (temperature, humidity, light exposure).
• Cell monolayer smear on slide by surface tension.
• Fixation method.
• Low temperature storage conditions.
• Pre-identification of cells by immunofluorescence staining and scanning.
• High cell viability and proliferation rate.
• Adherence efficiency of growing cells to the surface of the slide.
• Optimal seeding density on slide and growth conditions per cell line tested.
Sample staining critical steps
• Optimization of dewaxing and hydration procedures for FFPE tissue.
• Removal of tissue freezing matrix for frozen tissue. • Antigen retrieval and blocking conditions.
• Metal isotope labeling of validated antibody clones for tissue staining.
• Titration range testing of metal tag antibodies and DNA metallo-intercalators.
• Use of hydrophobic circle barrier around cells in specific regions for liquid staining on slide.
• Blocking conditions.
• Preparation of metal tag antibodies liquid cocktail.
• Washing and drying of the sample slide before acquisition.
• Metal tag antibodies panel specific to surface membrane, cytoplasm and nucleus of adherent cells.
• Chamber well liquid volume measurements for cell staining procedure.
• Fixation and permeabilization conditions.
• Removal of chamber wells from the slide.
Sample acquisition by IMC
• Simultaneous acquisition of all markers.
• Whole ablation of tissue regions.
• No autofluorescence.
• Plotting of two-dimensional coordinates of cells pre-identified by immunofluorescence.
• Laser ablation of areas with good cellular density and morphology.
• Regions of interest with intact cells.
• Ablation of areas with even cell monolayers rather than densely packed overlapping cells.
Data analysis challenges
• Pathology expertise required for IMC imaging data visualization.
• Annotation of structural and cellular regions.
• Segmentation of individual and distinct cells within tissue samples require nuclei and membrane markers.
• Single-cell segmentation of small-sized cells.
• Identification of nuclei with DNA metal-intercalator.
• Use of membrane stain for detection of cellular boundaries.
• Classification of cellular subpopulations.
• Single-cell morphological segmentation analysis.
• Nuclei segmentation with DNA metal-intercalator.
• Whole cell detection using cytoplasmic marker.
• Classification of different cell states. 
Multiplexing biological applications
